Coronary artery bypass grafting (CABG) is better than percutaneous coronary intervention (PCI) for adults with diabetes and multivessel coronary artery disease. In a definitive trial, those treated with CABG lived significantly longer and had significantly fewer myocardial infarctions than those treated with state of the art drug …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record








Social bookmarking